282 filings
8-K
GILD
Gilead Sciences, Inc.
9 May 24
Amendments to Articles of Incorporation or Bylaws
4:11pm
8-K
GILD
Gilead Sciences, Inc.
25 Apr 24
Gilead Sciences Announces First Quarter 2024 Financial Results
4:04pm
8-K
GILD
Gilead Sciences, Inc.
22 Mar 24
Gilead Sciences Announces Completion of Acquisition of Cymabay
9:21am
8-K
GILD
Gilead Sciences, Inc.
14 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
GILD
Gilead Sciences, Inc.
12 Feb 24
Entry into a Material Definitive Agreement
8:37am
8-K
xbgrl
6 Feb 24
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results
4:04pm
8-K
uvqx21
2 Feb 24
Ted Love, MD, Joins Gilead Sciences’ Board of Directors
4:20pm
8-K
4uls3mntl8ntdtrr2uo
7 Nov 23
Gilead Sciences Announces Third Quarter 2023 Financial Results
4:03pm
8-K
adp0r
14 Sep 23
Entry into a Material Definitive Agreement
9:00am
8-K
qpzh7vnoi07u
16 Aug 23
Regulation FD Disclosure
5:19pm
8-K
eykacuw
3 Aug 23
Gilead Sciences Announces Second Quarter 2023 Financial Results
4:07pm
8-K
ngoocf0yj72ohwdhu24
5 May 23
Departure of Directors or Certain Officers
11:15am
8-K
70jyig4cj2uzqb
27 Apr 23
Gilead Sciences Announces First Quarter 2023 Financial Results
4:05pm
8-K
b56dq3
6 Feb 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
ef6vbh4zw750arkn8
2 Feb 23
Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
8-K
79tx5vscib4f7l
27 Oct 22
Gilead Sciences Announces Third Quarter 2022 Financial Results
4:04pm
8-K
i0s64
12 Sep 22
Regulation FD Disclosure
8:00am
8-K
uhjc1f39
2 Aug 22
Gilead Sciences Announces Second Quarter 2022 Financial Results
4:05pm
8-K
f9yt3k
28 Jul 22
Departure of Directors or Certain Officers
4:01pm
8-K
ttuydcu4n1bw3fwsa7n
31 May 22
Departure of Directors or Certain Officers
4:01pm